Container Corporation of India Limited (NSE:CONCOR)

Lumos Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	36,631	1,935	3,437	3,849	6,784
Short-Term Investments	-	1,100	30,667	28,550	25,150	18,341
Cash & Short-Term Investments	37,731	37,731	32,602	31,988	28,999	25,125
Cash Growth	14.47%	15.73%	1.92%	10.31%	15.42%	17.47%
Accounts Receivable	-	4,000	3,336	2,160	1,817	1,610
Other Receivables	-	-	1,299	1,122	710.4	589.4
Receivables	-	4,161	4,790	3,424	2,644	2,306
Inventory	-	499.3	502.2	371.8	306.8	239.7
Prepaid Expenses	-	-	36.5	38.1	36.2	35.3
Other Current Assets	-	6,041	4,929	5,458	4,761	4,463
Total Current Assets	-	48,432	42,860	41,280	36,746	32,169
Property, Plant & Equipment	-	74,204	68,905	64,397	64,609	65,738
Long-Term Investments	-	10,094	11,071	11,043	12,169	12,334
Other Intangible Assets	-	123.6	169.2	177.8	172.2	114.9
Long-Term Deferred Tax Assets	-	324.9	821.5	925.3	1,082	694.8
Long-Term Deferred Charges	-	-	540.2	431	138.2	128.6
Other Long-Term Assets	-	11,034	15,559	15,985	14,624	12,483
Total Assets	-	144,759	140,380	134,652	130,010	124,103
Accounts Payable	-	2,243	2,810	3,821	4,223	2,693
Accrued Expenses	-	611.5	2,182	2,471	1,991	2,628
Current Portion of Long-Term Debt	-	-	20.1	63.6	63.6	63.6
Current Portion of Leases	-	1,553	1,664	1,068	1,099	799
Current Unearned Revenue	-	-	1,017	1,011	1,277	1,257
Other Current Liabilities	-	7,390	4,764	5,048	5,579	5,855
Total Current Liabilities	-	11,797	12,457	13,483	14,232	13,296
Long-Term Debt	-	242.5	242.2	491.3	554.7	618
Long-Term Leases	-	6,819	7,461	6,159	5,633	5,749
Long-Term Unearned Revenue	-	22.5	26.5	27.9	31.5	33.9
Other Long-Term Liabilities	-	90.4	136.8	461.8	129	118.8
Total Liabilities	-	19,893	21,115	21,371	21,448	21,191
Common Stock	-	3,047	3,047	3,047	3,047	3,047
Retained Earnings	-	-	115,008	109,104	104,493	98,999
Comprehensive Income & Other	-	120,755	177.6	112.7	-	-173.1
Total Common Equity	123,802	123,802	118,232	112,263	107,539	101,873
Minority Interest	-	1,064	1,033	1,018	1,022	1,040
Shareholders' Equity	124,866	124,866	119,265	113,281	108,562	102,912
Total Liabilities & Equity	-	144,759	140,380	134,652	130,010	124,103
Total Debt	8,615	8,615	9,387	7,781	7,350	7,229
Net Cash (Debt)	29,116	29,116	23,215	24,206	21,649	17,896
Net Cash Growth	23.51%	25.42%	-4.10%	11.81%	20.97%	6.11%
Net Cash Per Share	38.20	38.23	30.48	31.78	28.42	23.50
Filing Date Shares Outstanding	759.37	761.62	761.62	761.62	761.62	761.62
Total Common Shares Outstanding	759.37	761.62	761.62	761.62	761.62	761.62
Working Capital	-	36,635	30,403	27,797	22,514	18,873
Book Value Per Share	162.55	162.55	155.24	147.40	141.20	133.76
Tangible Book Value	123,678	123,678	118,063	112,085	107,367	101,758
Tangible Book Value Per Share	162.39	162.39	155.02	147.17	140.97	133.61
Land	-	-	5,960	5,823	5,800	5,796
Buildings	-	-	26,390	25,177	22,015	21,146
Machinery	-	-	54,486	46,544	46,460	41,865
Construction In Progress	-	-	8,783	8,230	7,447	9,193

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.